- recruitingTherapeutic confirmatory (Phase III)
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAVENOUS EFZOFITIMOD IN PATIENTS WITH PULMONARY SARCOIDOSIS
This study is testing a new medicine, Efzofitimod, for people with lung sarcoidosis. We want to see if it can help reduce the amount of steroid medication people need, while also checking if it's safe to use.
France · Netherlands · Spain - active not recruitingPHASE2
An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
This study looks more closely at a new medicine called XTMAB-16 for people with lung sarcoidosis. It aims to see if the treatment remains safe and effective over a longer time, including for those whose sarcoidosis affects other parts of their body too.
United States · Czechia · Poland - active not recruitingPHASE3
Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis
This study is testing a new drug, efzofitimod, for people with lung sarcoidosis. Researchers want to see if it's safe and helps improve symptoms compared to a dummy treatment over 48 weeks. It's for adults already taking steroids for their condition.
United States · Brazil · France - recruitingPHASE2
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis
This study is testing a new medicine, OATD-01, for people with active sarcoidosis in their lungs. We want to see if it helps improve symptoms and is safe to use. Some people will get the new medicine, and others will get a dummy medicine.
United States · Denmark · France - active not recruitingPHASE1, PHASE2
Study of Multiple-Ascending-Dose Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations
This study is looking into a new medicine, XTMAB-16, for people with lung sarcoidosis. It's an early-stage trial comparing XTMAB-16 to a dummy medicine (placebo) to see if it's safe and helps with the condition.
United States · Czechia · Denmark